home · filing · 0001683168-23-007145
8-K
filed October 13, 2023, 7:59 PM ET
ticker CPMD
CIK 0001081938
leadership
confidence high
sentiment neutral
materiality 0.50
CannaPharmaRX appoints Oliver Foeste as CFO; John Cassels departs without disagreement
CANNAPHARMARX, INC.
John Cassels replaced as CFO effective Oct 13, 2023; no disagreement with company on operations.
Oliver Foeste appointed CFO; founder of Invictus Accounting Group, CPA, senior finance roles at TSX, TSXV, NYSE issuers.
Foeste engaged in July 2023 for backup CFO services; compensation includes annual bonuses/stock options and hourly billing $65-$400.
No family relationships or material interests between Foeste and any director/officer.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Oliver Foeste
Chief Financial Officer
CPMD ·
CANNAPHARMARX, INC.
Effective 2023-10-13
Filed October 13, 2023, 7:59 PM ET
Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.
Departed
John Cassels
Chief Financial Officer
CPMD ·
CANNAPHARMARX, INC.
Effective 2023-10-13
Successor Oliver Foeste
Filed October 13, 2023, 7:59 PM ET
Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Oliver Foeste was appointed as Chief Financial Officer at CANNAPHARMARX, INC..
Action appointed
Role Chief Financial Officer
Exact text from the filing
Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Cassels departed as Chief Financial Officer at CANNAPHARMARX, INC..
Action replaced
Role Chief Financial Officer
Exact text from the filing
Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.
View on SEC.gov
Source: SEC EDGAR
accession 0001683168-23-007145
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.